CDEK
← All organizations

QED Therapeutics, Inc.

For profitWebsite ↗

Also known as: QED THERAP | QED Therapeutics | QED Therapeutics, Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Apr 30, 2019

First marketed drug

May 28, 2021

Last known activity

Nov 10, 2023

Timeline

2010s

  1. Jan 1, 2018

    QED Therapeutics, Inc.— Founded

2020s

  1. May 28, 2021

    infigratinib— Marketing Organization

Drugs by trial phase (6 distinct, 7 trials)

Phase 3 (3 own, 0 via acquisition)

Phase 1 (3 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Recent trials (12)

Details

Founded
Palo Alto, CA, US Jan 1, 2018
Last known activity
Nov 10, 2023